Weight loss drug could prevent type 2 diabetes

23 Feb 2017


Liraglutide, a weight loss drug, reduced type 2 diabetes risk in at-risk patients by 80%, according to a study published in The Lancet.

Express


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story